Jennifer L. King joined the firm as Of Counsel in 2024. Ms. King is a registered United States patent attorney and is experienced in worldwide patent portfolio management in the biotechnology, pharmaceutical, laboratory and medical device, and metallurgy fields. Ms. King became a patent attorney because she enjoys applying her understanding of diverse technologies to assist clients to succeed.
Ms. King has over twenty years of legal experience in a wide range of intellectual property matters. Practicing with law firms ranging from AmLaw100 general practice firms to intellectual property boutiques, Ms. King has counseled clients ranging from individual inventors to Fortune 500 corporations. In addition to the preparation and prosecution of patent applications, Ms. King also has broad experience with managing worldwide patent portfolios, landscape analyses, patentability analyses, freedom-to-operate analyses, opinion drafting, and negotiating and drafting patent licenses and related agreements.
Ms. King has also served as Senior Director, Assistant General Counsel at a long-standing biotechnology company, where she focused on genetic engineering. Ms. King advised stakeholders from the CEO and CFO through scientific researchers and marketing professionals regarding patents, trademarks, copyrights, intellectual property licensing, sponsored research agreements, material transfer agreements, and other legal matters. Ms. King assisted in directing Research and Development planning and activities, with a view toward patentability, freedom-to-operate, scientific feasibility, market acceptance, and return on investment.
Ms. King also has broad experience in patent adversarial proceedings. For example, Ms. King was second chair on a team that successfully defended the validity and enforceability of certain key patent claims at trial before a U.S. District Court. As another example, Ms. King was part of a team that negotiated a favorable settlement of an interference proceeding. Ms. King also has experience in appellate litigation, litigation before the International Trade Commission, and alternative dispute resolution.
Ms. King enjoys translating her litigation experience into drafting and prosecuting robust patent applications, drafting durable opinions, negotiating and drafting favorable licenses, and providing meaningful client counseling.
In addition to having earned a B.S. in Biology, Ms. King studied and worked in laboratories for two academic years in a Ph.D. program, with emphasis on genetics, molecular biology, biochemistry, transgenics, immunology, and virology.
Ms. King is conversant in Lean/Six Sigma implementation, and she actively practices and promotes a culture of and drive towards continuous improvement.
Education
Georgetown University Law Center, Juris Doctor, cum laude, 1999
The George Washington University, Genetics Ph.D. Program, course and laboratory work, 1994-1996
The George Washington University, Bachelor of Science, Biology, magna cum laude, 1994
Speeches
Publications
- HY Wang 1, J Zamorano, JL Yoerkie [married King], WE Paul, AD Keegan; “The IL-4-induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK1 expression in human fibrosarcoma cells”; J. Immunol. 1997 Feb. 1; 158(3):1037-40.
- Acknowledgment [as Jennifer L. Yoerkie] “for constructing the recombinant baculovirus clones” in DL Jones, et al.; “The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1 -mediated inhibition of cdk2”; Genes Dev. 1997 Aug. 15; 11(16): 2101–11.
- J. King and T. Herbert, “Seagate and Opinions of Counsel: Still A Sound Business Practice,” Intellectual Asset Management Magazine: Patents in the USA 2008: 40-43.
Admissions
District of Columbia Bar, 1999
Registered to Practice before the U.S. Patent and Trademark Office, 2000
United States District Court for the District of Columbia, 2007
United States Court of Appeals for the Federal Circuit, 2007
